Clinical Trial Update: A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in Bangladesh [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated two doses of an HRV vaccine given with or without OPV in healthy infants in Bangladesh and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infections

Drugs mentioned

• HRV vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Phase 2 | Status: COMPLETED